U.S. Pharmaceutical Sales - Q1 2011
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q1 2011. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q1 2011 by sales
- Sales Statistics Q1 2011
- Units*
Rank |
Drug |
Sales ($000) |
|
|
1 |
Lipitor
|
1,909,041 |
n/a |
Stats |
2 |
Plavix
|
1,655,111 |
n/a |
Stats |
3 |
Nexium AstraZeneca |
1,553,686 |
n/a |
Stats |
4 |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,232,457 |
n/a |
Stats |
5 |
Advair Diskus GlaxoSmithKline |
1,169,113 |
n/a |
Stats |
6 |
Seroquel AstraZeneca |
1,133,186 |
n/a |
Stats |
7 |
Crestor AstraZeneca |
1,048,141 |
n/a |
Stats |
8 |
Singulair Merck |
1,038,949 |
n/a |
Stats |
9 |
Actos Takeda Pharmaceutical Company Limited |
1,013,886 |
n/a |
Stats |
10 |
Cymbalta
|
820,197 |
n/a |
Stats |
11 |
Enbrel Amgen Inc. |
817,401 |
n/a |
Stats |
12 |
Remicade Janssen Pharmaceuticals, Inc. |
804,699 |
n/a |
Stats |
13 |
Zyprexa
|
800,446 |
n/a |
Stats |
14 |
Humira AbbVie Inc. |
794,076 |
n/a |
Stats |
15 |
Neulasta Amgen Inc. |
786,288 |
n/a |
Stats |
16 |
Copaxone Teva Pharmaceuticals USA, Inc. |
718,635 |
n/a |
Stats |
17 |
OxyContin Purdue Pharma LP |
706,496 |
n/a |
Stats |
18 |
Lexapro Allergan plc |
698,850 |
n/a |
Stats |
19 |
Epogen Amgen Inc. |
697,224 |
n/a |
Stats |
20 |
Rituxan Genentech, Inc. |
684,666 |
n/a |
Stats |
21 |
Avastin Genentech, Inc. |
658,284 |
n/a |
Stats |
22 |
Atripla Gilead Sciences, Inc. |
587,422 |
n/a |
Stats |
23 |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
557,860 |
n/a |
Stats |
24 |
Lantus Sanofi |
508,416 |
n/a |
Stats |
25 |
Levaquin Janssen Pharmaceuticals, Inc. |
470,549 |
n/a |
Stats |
26 |
Diovan Novartis Pharmaceuticals Corporation |
469,639 |
n/a |
Stats |
27 |
Januvia Merck |
468,525 |
n/a |
Stats |
28 |
Truvada Gilead Sciences, Inc. |
443,501 |
n/a |
Stats |
29 |
Celebrex
|
437,533 |
n/a |
Stats |
30 |
Lyrica
|
436,615 |
n/a |
Stats |
31 |
venlafaxine Generic |
430,495 |
n/a |
Stats |
32 |
Concerta Janssen Pharmaceuticals, Inc. |
421,050 |
n/a |
Stats |
33 |
Lucentis Genentech, Inc. |
420,635 |
n/a |
Stats |
34 |
Diovan HCT Novartis Pharmaceuticals Corporation |
404,945 |
n/a |
Stats |
35 |
Synagis MedImmune, Inc. |
403,493 |
n/a |
Stats |
36 |
Herceptin Genentech, Inc. |
384,428 |
n/a |
Stats |
37 |
Avonex Biogen |
370,570 |
n/a |
Stats |
38 |
OneTouch
|
359,697 |
n/a |
Stats |
39 |
Namenda Allergan plc |
349,433 |
n/a |
Stats |
40 |
Gleevec Novartis Pharmaceuticals Corporation |
347,690 |
n/a |
Stats |
41 |
Lantus Solostar Sanofi |
333,878 |
n/a |
Stats |
42 |
Zetia Merck |
331,879 |
n/a |
Stats |
43 |
TriCor AbbVie Inc. |
324,053 |
n/a |
Stats |
44 |
Geodon
|
323,066 |
n/a |
Stats |
45 |
Lovenox Sanofi |
321,041 |
n/a |
Stats |
46 |
donepezil Generic |
312,985 |
n/a |
Stats |
47 |
enoxaparin Generic |
311,579 |
n/a |
Stats |
48 |
Procrit Janssen Pharmaceuticals, Inc. |
310,606 |
n/a |
Stats |
49 |
Vyvanse Takeda Pharmaceutical Company Limited |
309,394 |
n/a |
Stats |
50 |
Niaspan AbbVie Inc. |
301,309 |
n/a |
Stats |
51 |
Aranesp Amgen Inc. |
294,912 |
n/a |
Stats |
52 |
Lidoderm Endo Pharmaceuticals Inc. |
291,819 |
n/a |
Stats |
53 |
Suboxone
|
284,350 |
n/a |
Stats |
54 |
Vytorin Merck |
276,781 |
n/a |
Stats |
55 |
Nasonex Merck |
267,495 |
n/a |
Stats |
56 |
AndroGel AbbVie Inc. |
265,323 |
n/a |
Stats |
57 |
Taxotere Sanofi |
262,205 |
n/a |
Stats |
58 |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
261,226 |
n/a |
Stats |
59 |
Viagra
|
255,034 |
n/a |
Stats |
60 |
Prevnar 13 Pfizer Inc. |
254,201 |
n/a |
Stats |
61 |
Rebif EMD Serono, Inc. |
253,143 |
n/a |
Stats |
62 |
Symbicort AstraZeneca |
250,905 |
n/a |
Stats |
63 |
Adderall XR Takeda Pharmaceutical Company Limited |
248,516 |
n/a |
Stats |
64 |
Flovent HFA GlaxoSmithKline |
246,705 |
n/a |
Stats |
65 |
Lovaza GlaxoSmithKline |
244,967 |
n/a |
Stats |
66 |
Novolog Novo Nordisk |
244,297 |
n/a |
Stats |
67 |
Alimta Eli Lilly and Company |
242,617 |
n/a |
Stats |
68 |
Seroquel XR AstraZeneca |
242,586 |
n/a |
Stats |
69 |
metoprolol Generic |
238,586 |
n/a |
Stats |
70 |
Provigil
|
234,569 |
n/a |
Stats |
71 |
Aciphex Eisai Inc. |
234,407 |
n/a |
Stats |
72 |
Humalog Eli Lilly and Company |
232,809 |
n/a |
Stats |
73 |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
230,795 |
n/a |
Stats |
74 |
Neupogen Amgen Inc. |
230,515 |
n/a |
Stats |
75 |
amphetamine/dextroamphetamine Generic |
230,361 |
n/a |
Stats |
76 |
Reyataz Bristol-Myers Squibb Company |
227,624 |
n/a |
Stats |
77 |
budesonide Generic |
220,600 |
n/a |
Stats |
78 |
fentanyl Generic |
217,863 |
n/a |
Stats |
79 |
Lunesta Sunovion Pharmaceuticals Inc. |
200,317 |
n/a |
Stats |
80 |
Levemir Novo Nordisk |
198,403 |
n/a |
Stats |
81 |
Cialis Eli Lilly and Company |
189,406 |
n/a |
Stats |
82 |
Zyvox Pfizer Inc. |
186,128 |
n/a |
Stats |
83 |
valacyclovir Generic |
184,765 |
n/a |
Stats |
84 |
Femara Novartis Pharmaceuticals Corporation |
184,415 |
n/a |
Stats |
85 |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
182,908 |
n/a |
Stats |
86 |
Tamiflu
|
182,553 |
n/a |
Stats |
87 |
Xalatan
|
179,478 |
n/a |
Stats |
88 |
Zometa Novartis Pharmaceuticals Corporation |
177,636 |
n/a |
Stats |
89 |
Janumet Merck |
177,253 |
n/a |
Stats |
90 |
Restasis Allergan plc |
176,652 |
n/a |
Stats |
91 |
Evista
|
176,440 |
n/a |
Stats |
92 |
Solodyn Medicis Pharmaceutical Corporation |
175,489 |
n/a |
Stats |
93 |
NovoLog FlexPen Novo Nordisk |
175,235 |
n/a |
Stats |
94 |
Benicar Daiichi Sankyo |
174,621 |
n/a |
Stats |
95 |
Erbitux Eli Lilly and Company |
173,735 |
n/a |
Stats |
96 |
azithromycin Generic |
173,584 |
n/a |
Stats |
97 |
bupropion Generic |
172,612 |
n/a |
Stats |
98 |
Detrol LA Viatris |
170,550 |
n/a |
Stats |
99 |
AMLODIP BES/BENAZ
|
170,503 |
n/a |
Stats |
100 |
Isentress Merck |
170,024 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.